Skip to main content
Back
Watch Compare

CTT PHARMACEUTICAL HOLDINGS, INC.

Data quality: 83%
CTTH
OTC Energy Metal Mining
$0.06
▼ $0.01 (-12.86%)
6 months return
—
Momentum
Neutral
1Y earnings growth
106.26%

Growth

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)106.26%
FCF Growth (3Y)N/A

Quality

Return on Equity
-89.30%
Below sector avg (3.74%)
ROIC-72.02%
Net MarginN/A
Op. MarginN/A

Safety

Debt / Equity
N/A
Current RatioN/A
Interest CoverageN/A

Valuation

PE (TTM)
-4.97
Below sector avg (3.45)
P/B Ratio5.18
EV/EBITDAN/A
Dividend YieldN/A

Quick Summary

Key Takeaways

Short bullets derived from reported financials—not the AI summary above.

Earnings grew 106.26% over the past year
Negative free cash flow of -131,174.0

Price History

Financial Trends

Analyst Price Target

No analyst coverage available

Growth

Rev 5Y: N/A · Earnings 1Y: 106.26%
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) 106.26% Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A

Profitability

ROE: -89.30% · Net Margin: N/A
Revenue (TTM) N/A Net Income (TTM) -770,159.0
ROE -89.30% ROA -73.16%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -131,174.0
ROIC -72.02% FCF Growth (3Y) N/A

Safety

D/E: N/A · Current: N/A
Debt / Equity N/A Current Ratio N/A
Interest Coverage N/A Asset Turnover N/A
Working Capital N/A Tangible Book Value 738,078

Dividends

Yield: N/A · Payout: N/A
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A

Valuation

P/E: -4.97 · EV/EBITDA: N/A
P/E Ratio -4.97 Forward P/E N/A
P/B Ratio 5.18 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -3.43%
Market Cap 3.82 M Enterprise Value 3.79 M

Per Share

EPS: N/A · FCF/Share: 0.00
EPS (Diluted TTM) N/A Revenue / Share N/A
FCF / Share 0.00 OCF / Share 0.00
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A

Efficiency

FCF Conv: 17.03% · CapEx/Rev: N/A
CapEx / Revenue N/A FCF Conversion 17.03%
SBC-Adj. FCF -270,398 Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2014 FY2013 FY2012 FY2011
Revenue — — — —
Net Income 227,838.0 110,464.0 -1.00 M 3.74 M
EPS (Diluted) — 0.01 -0.11 0.40
Gross Profit — — — —
Operating Income -672,162.0 92,201.0 -1.19 M -757,935.0
EBITDA — — — —
R&D Expenses — — — —
SG&A Expenses — — — —
D&A — — — 0.0
Interest Expense — — — —
Income Tax — — — —

Balance Sheet

Annual, most recent first
Metric FY2014 FY2013 FY2012 FY2011
Total Assets 1.66 M 6,252.0 203,079.0 4.18 M
Total Liabilities 1.08 M 249,378.0 589,413.0 3.73 M
Shareholders' Equity 586,630.0 -243,126.0 -386,334.0 456,450.0
Total Debt — — — —
Cash & Equivalents 81,179.0 823.0 12,091.0 569,378.0
Current Assets 1.05 M 6,252.0 203,079.0 750,734.0
Current Liabilities — 249,378.0 589,413.0 3.73 M

Peer Comparison

vs Energy sector median (644 peers)
Metric Stock Sector Median
P/E -5.0 3.5
P/B 5.2 2.1
ROE % -89.3 3.7
Net Margin % — 4.9
Rev Growth 5Y % — 9.4
D/E — 0.5